These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18038274)

  • 1. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.
    Mattern J; Wayss K; Volm M
    In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
    Uchida J; Satake H; Saito H; Nakano K; Takeda S; Unemi N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1001-8. PubMed ID: 8210249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
    Fujita F; Fujita M; Sakamoto Y; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of trimetrexate in combination with cisplatin.
    Hudes GR; LaCreta F; Walczak J; Tinsley P; Litwin S; Comis RL; O'Dwyer PJ
    Cancer Res; 1991 Jun; 51(12):3080-7. PubMed ID: 1828188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC; Kaufmann SH
    Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum time sequence for the administration of cyclophosphamide and other drugs in vivo.
    Mattern J; Wauss K; Volm M
    Anticancer Res; 1985; 5(2):173-8. PubMed ID: 4039550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent effectiveness of ADM and multiple cycles of DDP on a murine reticulum sarcoma.
    Leonetti C; Zupi G; Calabresi F; Greco C
    Anticancer Res; 1990; 10(1):45-8. PubMed ID: 2185688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
    J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.
    Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F
    Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.
    Kruczynski A; Kiss R
    Anticancer Res; 1993; 13(2):507-13. PubMed ID: 7685990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
    Dorie MJ; Brown JM
    Cancer Res; 1993 Oct; 53(19):4633-6. PubMed ID: 8402639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity of human pancreatic cancer cell lines serially transplanted in nude mouse.
    Tomikawa M; Kubota T; Takahashi S; Matsuzaki SW; Kitajima M
    Anticancer Res; 1998; 18(2A):1059-62. PubMed ID: 9615765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
    Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
    Pan XY; Li FQ; Yu RJ; Xie GF; Wang H; Zhao LY; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):15-8. PubMed ID: 2843330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.